FI54802C - Foerfarande foer framstaellning av terapeutiskt anvaendbar 1-(2-hydroxietyl)-2-(p-fluorfenyl)-5-nitroimidazol - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbar 1-(2-hydroxietyl)-2-(p-fluorfenyl)-5-nitroimidazol

Info

Publication number
FI54802C
FI54802C FI136271A FI136271A FI54802C FI 54802 C FI54802 C FI 54802C FI 136271 A FI136271 A FI 136271A FI 136271 A FI136271 A FI 136271A FI 54802 C FI54802 C FI 54802C
Authority
FI
Finland
Prior art keywords
therapeutic
hydroxythyl
fluorphenyl
nitroimidazole
fruit protection
Prior art date
Application number
FI136271A
Other languages
English (en)
Finnish (fi)
Other versions
FI54802B (fi
Inventor
Janos Kollonitsch
Stephen Marburg
Ludwig Salce
Erwin Frederick Schoenewaldt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of FI54802B publication Critical patent/FI54802B/fi
Application granted granted Critical
Publication of FI54802C publication Critical patent/FI54802C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/93Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by halogen atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91Nitro radicals
    • C07D233/92Nitro radicals attached in position 4 or 5
    • C07D233/94Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI136271A 1970-05-25 1971-05-18 Foerfarande foer framstaellning av terapeutiskt anvaendbar 1-(2-hydroxietyl)-2-(p-fluorfenyl)-5-nitroimidazol FI54802C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4044770A 1970-05-25 1970-05-25
US4044970A 1970-05-25 1970-05-25

Publications (2)

Publication Number Publication Date
FI54802B FI54802B (fi) 1978-11-30
FI54802C true FI54802C (fi) 1979-03-12

Family

ID=26717075

Family Applications (1)

Application Number Title Priority Date Filing Date
FI136271A FI54802C (fi) 1970-05-25 1971-05-18 Foerfarande foer framstaellning av terapeutiskt anvaendbar 1-(2-hydroxietyl)-2-(p-fluorfenyl)-5-nitroimidazol

Country Status (11)

Country Link
JP (1) JPS5516141B1 (cs)
AR (1) AR195147A1 (cs)
CA (1) CA939362A (cs)
CH (1) CH579056A5 (cs)
CS (1) CS178861B2 (cs)
ES (1) ES391433A1 (cs)
FI (1) FI54802C (cs)
HU (1) HU164641B (cs)
NL (1) NL7104806A (cs)
NO (1) NO132591C (cs)
SE (1) SE392897B (cs)

Also Published As

Publication number Publication date
FI54802B (fi) 1978-11-30
CS178861B2 (en) 1977-10-31
SE392897B (sv) 1977-04-25
HU164641B (cs) 1974-03-28
NO132591B (cs) 1975-08-25
NO132591C (cs) 1975-12-03
CA939362A (en) 1974-01-01
NL7104806A (cs) 1971-11-29
CH579056A5 (en) 1976-08-31
AR195147A1 (es) 1973-09-19
ES391433A1 (es) 1974-08-16
JPS5516141B1 (cs) 1980-04-30

Similar Documents

Publication Publication Date Title
BE781055A (fr) Triazoles
FI54301C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat
IT1050427B (it) Procedimento per la preparazione di margarina fluida
BE765019A (nl) Gebruiksverpakking
SE408551B (sv) Forfarande for framstellning av vissa angivna n-substituerade-beta-amino-alfa-bensylakrylnitrilderivat av hog renhet
SE388422B (sv) Forfarande for reduktion av theabin
FI55184B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer
IT1033044B (it) Procedimento per la preparazione di ciclosilossani
IT945790B (it) Procedimento per il trattamento preliminare di composizioni elettrodepositabili
BE781056A (fr) Triazoles
FI55196B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 4-(bensoxazol-2-yl)-fenylaettiksyraderivat
FI54104B (fi) Foerfarande foer framstaellning av terapeutiskt verksamma pyrrolidinonfoereningar
AT306467B (de) Rückschlagsicherung
IT942433B (it) Procedimento per la preparazione di azine
FI55988C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer
FI53700C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat
IT945769B (it) Composti di poliamidammonio loro preparazione ed impiego
IT1050187B (it) Procedimento e composizioni per l addolcimento di composti di diidrocalcone
FI54802C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbar 1-(2-hydroxietyl)-2-(p-fluorfenyl)-5-nitroimidazol
FI56378B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 1-(4-bromfenyl)-1-pyridyl-3-dimetylamino-prop-1-enderivat
BG18610A3 (bg) Метод за получаване на 1-(2'-хидроксиетил)-2- метил-5-нитроимидазол
IT960128B (it) Agenti di protezione delle sementi
IT939836B (it) Procedimento ed apparecchio per il trattamento di materiali elasto meri
AT324538B (de) Elektromedizinische gerätegruppe
IT1051240B (it) Procedimento per la preparazione di zeaxantina